Where Biologic Stability Programs Fail—and How ICH Q1 Can Help You Get It Right

Integrated Thinking for Complex FIH Programs

See how deep expertise, integrated thinking, and cross-functional collaboration turn complex molecule challenges into opportunities, strengthening early decisions and improving First‑in‑Human outcomes.

Four Common Pitfalls To Avoid In UF/DF Setup And Scale-Up

Learn how small UF/DF decisions can create major scale-up challenges, as well as practical ways to improve membrane selection, reduce manual operations, and boost PD–MSAT alignment.

Bridging Discovery And CMC With Rapid Pools

Learn how early stable CHO expression data reveals manufacturability issues in complex antibodies that transient screening misses, with case studies showing how this changes lead selection.

Selecting A Prefillable Syringe System With Confidence

Discover an advancement in the prefillable syringe market, uniquely integrating the syringe barrel, plunger, and needle shield/tip cap into a fully harmonized, verified system from a single supplier.

Designing Drug Substance Processes For Fill-Finish Compatibility

Integrated KBI and Argonaut solutions streamline drug substance to fill-finish transitions, resolving quality challenges, reducing delays, and accelerating timelines through coordinated processes and practical strategies.

Building Digitally Connected Packaging Operations With Open Standards

Connect shopfloor equipment with enterprise systems to streamline your data flow. Learn how automation standards enhance integration and see a live demonstration of unified line performance in action.

Simplified Harvest And Media Exchange In Cell Therapy

Scale-up often introduces shear stress and process variability. Learn how low-shear, single-use technology stabilizes media exchange and harvest, ensuring consistent cell quality and predictable performance.

Next-Level Cell Lines: An Integrated Approach To Biologic Innovation

See how AI-driven tools and optimized platforms are accelerating biologics development, delivering high-titer clones in weeks, and paving the way for integrated design of cell lines and genetic systems.

Five Practical Considerations To Move From Concept To Clinic

Learn more about five key factors for advancing targeted in vivo LNP programs, from formulation and targeting strategies to bioanalytical readiness and scalability.

Overcoming Regulatory Hurdles In AAV Production

Demonstrating residual reagent clearance is a critical regulatory requirement in AAV manufacturing. Explore how specialized assays and strategic partnerships streamline compliance.

From Lab To Commercialization: Simplifying Bioprocess Scale-Up

Explore how unique cuboid geometries and advanced mixing dynamics create consistent performance from the bench to commercial manufacturing, ensuring flexibility and improved productivity.

Bridging The Gap Between Product Readiness And Equipment Availability

Discover how manual precision at scale bridges packaging gaps, accelerates product launches, and ensures uninterrupted supply to deliver quality when automated equipment isn’t yet operational.

Automating Visual Inspection Qualification

Transferring visual inspection data from paper to digital is essential for Pharma 4.0 compliance. Learn practical strategies to eliminate errors, automate data tracking, and enhance quality assurance.

When A Logbook Project Becomes A Digital Movement

A leading pharma company accelerated execution and compliance in GMP operations. See how modular apps replaced manual processes, setting a new foundation for continuous innovation.

Seal The Deal: Mastering Vent Integration In Medical Devices

Learn how precise vent placement and microfiltration design optimize performance in life science devices. See practical troubleshooting strategies and a real-world case study.

Lessons From FDA 483s And Warning Letters: Cleanroom Compliance

Learn critical lessons from FDA 483 observations and Warning Letters to proactively address common GMP cleanroom compliance failures and build an inspection-ready facility.

Eliminate Risk From Your Viral Vector Tech Transfers

Explore strategies to simplify viral vector tech transfers, reduce risk, and maintain quality under tight timelines, as well as a case study that demonstrates how to streamline this critical process.

Navigating Innovation And Challenges In CGT Bioprocessing

This expert panel breaks down the practical realities of today’s supply chain while forecasting how emerging technologies will redefine quality standards.

Navigating Regulatory Expectations For Injectable Packaging

Explore insights on extractables, focusing on how they relate to the revised EU GMP Annex 1, new and evolved expectations under USP <382>, and the use of VHP decontamination in aseptic environments.

Unlock Productivity In mAb Production: Upstream And Downstream Intensification

Boost your mAb manufacturing efficiency by mastering upstream and downstream intensification strategies. Learn how to minimize cost and time while increasing overall productivity.

Critical Path For Gene Therapy: AAV Analytical Lifecycle Considerations

Explore considerations for phase-appropriate AAV characterization and release activities from pre-clinical to late-phase products. Review validation challenges and paths for maturation of analytics.

Raising The Bar In Gene Therapy

Learn how a science-driven and digitally structured approach reduced onboarding timelines for gene therapy from 12 months to just 3, setting a new benchmark in technology transfers.

The mRNA Journey: From Design To LNP-Ready Molecules For Research

Learn a validated, end-to-end protocol for producing high-quality in vitro transcription (IVT) mRNA for preclinical research. Find out how to optimize sequence design, small-scale synthesis, and more.

Smart Media Screening And Design: Saving Time And Boosting Titers

Optimizing your cell culture media selection is crucial for clinical advancement. Learn how high throughput screening techniques accelerate media and feed optimization to significantly boost your biologics' titers.

Streamlining pDNA: Capacity, Complexity, And Cutting-Edge Solutions

Learn how flexible facility design and process innovation are accelerating pDNA manufacturing, as well as key strategies to avoid scale-up pitfalls and meet growing therapeutic demand.

Are You Keeping Pace With Oligo Synthesis Optimization?

The rapidly expanding oligo market demands optimized RNA synthesis. Examine key innovations and workflow insights to maximize resources and control long-term manufacturing costs.

From Readiness To Results: Unlocking Capacity For Expanding Product Demand

Learn the six pillars that bridge operational readiness and operational excellence. Discover a proven framework to build a resilient, high-performing manufacturing operation and unlock necessary capacity.

Accelerate Your pDNA And mRNA Process Development

Explore a structured approach to optimizing and scaling plasmid DNA production using E. coli, with insights into key growth parameters, benchtop feasibility, and pilot-scale performance.

Driving Robust Tech Transfer In Biologics: Computational Fluid Dynamics (CFD) Simulation

Computational Fluid Dynamics simulation is essential for robust biologics tech transfer. See how this predictive tool optimizes critical scale-up processes, reducing risk and expediting time to market.